🇺🇸 FDA
Patent

US 11883433

Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

granted A61KA61K2039/505A61K2239/11

Quick answer

US patent 11883433 (Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof) held by CELLENGENE INC. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CELLENGENE INC.
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K2239/11, A61K2239/21, A61K2239/31